Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-6.9%
5Y CAGR+18.7%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-6.9%/yr
Annual compound
5Y CAGR
+18.7%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$10.66M-13.3%
2024$12.29M-9.2%
2023$13.53M+2.3%
2022$13.23M+31.9%
2021$10.03M+121.8%
2020$4.52M+30.9%
2019$3.45M-